Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135562 · ClinicalTrials.gov registry record · NA
Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02135562: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT02135562 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02135562, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This pilot clinical trial studies protein-sparing modified fast (PSMF) intervention for weight loss in obese endometrial cancer survivors. The PSMF is a diet that is very low in carbohydrates and calories, designed to induce fast, safe weight loss. The diet consists of only lean meats (beef, pork, poultry, and seafood) in amounts adequate to meet protein requirements based on the individual's body weight. The PSMF may help endometrial cancer survivors achieve significant weight loss, reduce the risk of chronic disease, and improve quality of life.
Primary Outcome
Mean weight loss will be presented as mean total weight loss in kilograms from baseline
Interventions
- DIETARY_SUPPLEMENT Dietary Intervention
- OTHER Informational Material
- OTHER Dietary Education
- DIETARY_SUPPLEMENT Weight Maintenance
- OTHER Average score of Obesity and Weight-Loss Quality of Life Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-08-08 |
| Est. Completion | 2017-04-19 |
| Phase | NA |
What the finished NCT02135562 record still lists
NCT02135562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Dietary Intervention is the first listed.
NCT02135562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02135562 about?
NCT02135562 is a clinical study titled "Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors". This pilot clinical trial studies protein-sparing modified fast (PSMF) intervention for weight loss in obese endometrial cancer survivors. The PSMF is a diet that is very low in carbohydrates and calories, designed to induce fast, safe weight loss. The diet consists of only lean meats (beef, pork, p...
What is the current status of trial NCT02135562?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-08-08. Estimated completion is 2017-04-19.
What interventions are being tested in trial NCT02135562?
The interventions under investigation include: Dietary Intervention (DIETARY_SUPPLEMENT), Informational Material (OTHER), Dietary Education (OTHER), Weight Maintenance (DIETARY_SUPPLEMENT), Average score of Obesity and Weight-Loss Quality of Life Questionnaire (OTHER).
Who is sponsoring clinical trial NCT02135562?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02135562's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI